Pyelonephritis
Drug Market Size, Share, Growth, Trends, Analysis and Forecast - 2031

The
global pyelonephritis drug market is anticipated to grow at a significant CAGR
during the forecast period (2024-2031). A kidney infection, commonly known as
pyelonephritis, is a form of urinary tract infection characterized by
inflammation of one or both kidneys. Bacteria or a virus causes the illness,
which usually starts in the urinary bladder and spreads to one or both kidneys.
Confusion and back pain, chills and high fever, nausea and vomiting, back,
side, and groyne discomfort, and painful urination are all signs or symptoms of
pyelonephritis, which might vary based on age. Kidney stones, a weaker immune
system, anatomical abnormalities with the urinary tract, urine reflux issues,
and nerve damage surrounding the bladder are all some factors that cause
pyelonephritis. Owing to the high prevalence and incidence rates of
pyelonephritis problems around the world, the global pyelonephritis treatment
market is expected to rise rapidly during the forecast period. Each year, over
200,000 hospitalizations for acute pyelonephritis are reported in the US. As a
result, the global pyelonephritis treatment market is likely to be driven by a
huge population base with a kidney infection during the forecast period.

Get Free Sample link @ https://www.omrglobal.com/request-sample/pyelonephritis-drug-market

The
key companies operating in the industry are highly inclined towards the
adoption of different growth strategies including partnerships and
collaborations, mergers and acquisitions, geographical expansion, and new
product launches, to remain competitive in the marketplace. For instance, in
October 2021, Spero Therapeutics, Inc., a multi-asset clinical-stage
biopharmaceutical company focused on identifying, developing, and
commercializing treatments for multi-drug resistant bacterial infections and rare
diseases, announced that it has submitted a new drug application (NDA) to the
US Food and Drug Administration (FDA) for approval of tebipenem HBr tablets for
the treatment of complicated urinary tract infections (cUTI) including
pyelonephritis, caused by susceptible microorganisms. 

Full report of Pyelonephritis Drug Market available @ https://www.omrglobal.com/industry-reports/pyelonephritis-drug-market

Market
Coverage

Segment
Covered- 

• By Product Type


• By Application

Regions
Covered-

• North America


• Europe


• Asia-Pacific


• Rest of the World

Competitive
Landscape- Merck & Co, Inc., and AstraZeneca plc, among others. 

Key
questions addressed by the report

• What is the market growth
  rate?


• Which segment and region
  dominate the market in the base year?


• Which segment and region
  will project the fastest growth in the market?


• How has COVID-19 impacted
  the market?

o             Deviation from the pre-COVID-19
forecast

o             Most affected region and segment

• Who is the leader in the
  market?


• How players are addressing
  challenges to sustain growth?


• Where is the investment
  opportunity?

Global
Pyelonephritis Drug Market Report by Segment

By
Product Type

• Finafloxacin


• Fosfomycin Tromethamine


• Nacubactam


• Plazomicin Sulfate


• Others

By
Application

• Hospital


• Clinic


• Others

Reasons to Buying From us -



1. We cover more than 15 major industries, further segmented into more than 90
sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after
purchasing your report.

For
More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pyelonephritis-drug-market

Media Contact:



Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research



About Orion Market Research



Orion Market Research (OMR) is a market research and consulting company known
for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services. The company also offers Digital Marketing services through its
subsidiary OMR Digital and Software development and Consulting Services through
another subsidiary Encanto Technologies.